Correction to: LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells (Cancer Immunology, Immunotherapy, (2023), 72, 7, (2179-2193), 10.1007/s00262-023-03395-6)

doi:10.1007/s00262-023-03426-2

科研成果详情

名称	Correction to: LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells (Cancer Immunology, Immunotherapy, (2023), 72, 7, (2179-2193), 10.1007/s00262-023-03395-6)
作者	Wu, Peitao 1; Guo, Yuhang 2; Xiao, Li 1; Yuan, Jiaqi 1; Tang, Chao 3; Dong, Jun 1; Qian, Zhiyuan 1
发表期刊	Cancer Immunology, Immunotherapy;
语种	英语
原始文献类型	Erratum
摘要	The original version of this article unfortunately contained a mistake. The corrected details are given below for your reading. Equal contributor statement was missing. Equal contributor statement should be "Yuhang Guo is the co-first author". The statistical result in Fig. 2B has some mistakes. The statistical analysis was not markered in Fig. 3A, C and F, and the statistical analysis result of Fig. 3B was misplaced. The corrected Figs. 2 and 3 are given in the following page. (Figure presented.) (Figure presented.) Pirb promotes GBM progression through an immunosuppressive TME. A The proliferation of GL261-LV-nc, GL261-pirb+, GL261-nc and GL261-pirb− cells detected by CCK8 assays at 24, 48 and 72 h. Statistical analysis of cell apoptosis B, migration C and invasion D in GL261-LV-nc, GL261-pirb+, GL261-nc and GL261-pirb− cells. The presence of MDSCs E, Tregs F, CD4+ and CD8+ T cells G in human GBM tissue detected by IF. P < 0.05, * P < 0.01, *P < 0.001, or *P < 0.0001, ns indicates no statistical significance High pirb expression leads to immunosuppression. The percentages of MDSCs A, Tregs B, CD8+ T cells C and CD4+ cells D in the tumor sites detected by flow cytometry. The percentages of CD8+ T cells E, MDSCs F, CD4+ T cells G and Treg cells H in the spleens of tumor-bearing mice detected by flow cytometry. P < 0.05, P < 0.01, P < 0.001, or ***P < 0.0001, ns indicates no statistical significance The original article has been corrected.
出版者	Springer Science and Business Media Deutschland GmbH
ISSN	0340-7004
EISSN	1432-0851
卷号	72
期号	7
页码	2195-2196
DOI	10.1007/s00262-023-03426-2
WOS记录号	WOS:000973544200002
收录类别	SCOPUS
发布日期	2023-07-01
URL	查看原文
PubMed ID	37067555
通讯作者地址	[Dong, Jun;Qian, Zhiyuan]Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou 215000, Peoples R China. ; [Tang, Chao]Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China.
Scopus学科分类	Immunology and Allergy;Immunology;Oncology;Cancer Research
SCOPUSEID	SCOPUS_ID:85152787720
引用统计
文献类型	其他
条目标识符	https://kms.wmu.edu.cn/handle/3ETUA0LF/184832
专题	附属第一医院_神经外科
通讯作者	Tang, Chao; Dong, Jun; Qian, Zhiyuan
作者单位	1.Soochow Univ, Affiliated Hosp 2, Dept Neurosurg, Suzhou 215000, Peoples R China; 2.Wenzhou Med Univ, Affiliated Hosp 1, Dept Neurosurg, Wenzhou, Peoples R China; 3.Huashan Hosp, Dept Neurosurg, Shanghai, Peoples R China
推荐引用方式 GB/T 7714	Wu, Peitao,Guo, Yuhang,Xiao, Li,et al. Correction to: LILRB2-containing small extracellular vesicles from glioblastoma promote tumor progression by promoting the formation and expansion of myeloid-derived suppressor cells (Cancer Immunology, Immunotherapy, (2023), 72, 7, (2179-2193), 10.1007/s00262-023-03395-6). 2023.